Search filters

List of works by Gregor Eisenwort

CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

scientific article published on 16 November 2016

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

scientific article published on 11 September 2014

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

scientific article published on 8 June 2017

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms

scientific article published on 24 September 2018

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia

scientific article

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

scientific article published on 29 November 2017

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia

scientific article published on 12 October 2017

Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.

scientific article published on 27 April 2017

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H

scientific article published on 26 November 2013

Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation

scientific article

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

scientific article published on 25 November 2015

Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells

scientific article published on 16 June 2011

Identification of a leukemia-initiating stem cell in human mast cell leukemia

scientific article published on 05 April 2019

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

scientific article published on 9 June 2015

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

scientific article

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML

scientific article published on 29 August 2019

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.

scientific article published on 31 July 2017

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells

scientific article published on 15 January 2015

Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells

scientific article

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.

scientific article published on 29 April 2016

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

scientific article

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

scientific article published on 8 February 2018

The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells.

scientific article published on 28 June 2017

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

scientific article published on 19 September 2013

Variability of PD-L1 expression in mastocytosis

scientific article published on 01 February 2018

β-Catenin promotes the differentiation of epidermal Langerhans dendritic cells

scientific article published on 10 January 2013